Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Zolis .....too long to read your post but let me

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 301)
Posted On: 01/06/2021 1:31:17 PM
Posted By: GMIN
Re: Zolis_onkel #25065
Zolis .....too long to read your post but let me summarize the years ....2018 .....wooow incredible news , 2019.......k , not that easy but understand delays, 2020 ......what's up?????........2021...... hopefully not ....are you kidding me !!!
It's time to produce with with all the hype of leading edge, Merck, Altucell closing, AE37 recruitment. revenue generating acquisitions, AZ revenue, SEC delaying listing...., waiting for better valuation?? , world-class Management. So far money talks BS walks and we continue to walk.
Like I said before I believe in von Hofe/Epivax but forward looking business deals based on past decisions...... questionable at best. Of course if funds show up we have to worry about the investment strategy...........oh yes ......the 2.50 pps turned into a complete miscalculated vision !!! What's next ??
Nasdaq listing and solid institutional support is necessary to be successful but unfortunately most credible institutions conduct due-diligence and decide based on potential - CEO/Management.
Glad you are happy with the progress and continue to support current business decisions and I assume the lucrative CHINA deal !!! I'm all for compensation for hard working people if any results. Stick with the bonus for now until we have a solid stable listing or restrict shares like TC mentioned.
If this company has World class Management and the best vaccine potential we should be able to convince Big Pharma.............maybe even our friends at Merck .....how many people recruited so far ? Last PR I believe was Sept 2019????

https://clinicaltrials.gov/ct2/show/record/NC...amp;rank=1


(2)
(1)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us